Literature DB >> 16979073

Abdominal magnetic resonance imaging at 3.0 T what is the ultimate gain in signal-to-noise ratio?

Sebastian T Schindera1, Elmar M Merkle, Brian M Dale, David M Delong, Rendon C Nelson.   

Abstract

RATIONALE AND
OBJECTIVES: The purpose of this study was to calculate the gain in signal-to-noise ratio (SNR) of four human abdominal tissues at 3.0 Tesla (T) compared with standard 1.5 T and to validate this calculation in vivo.
MATERIALS AND METHODS: The expected gain in SNR at 3.0 T in the liver, pancreas, spleen, and kidney compared with standard 1.5 T was approximated theoretically for a T2-weighted HASTE (half-Fourier acquisition single-shot turbo spin-echo) and a T1-weighted gradient-echo in- and opposed-phase sequence. Fifteen healthy male subjects underwent abdominal MR imaging using a 1.5 T and 3.0 T scanner. Coronal T2-weighted HASTE images and axial T1-weighted gradient-echo in- and opposed-phase images were acquired using the sequence parameters optimized by the vendor.
RESULTS: Except for opposed-phased imaging of pancreatic tissue, in vivo adjusted SNR values of all abdominal tissues were significantly higher at 3.0 T for all sequences (P < .05). The highest overall gain in SNR was achieved with the HASTE sequence ranging from 3.8-fold for renal imaging to 7.4-fold for hepatic imaging. The theoretical calculation of SNR gain was in good agreement with the experimentally measured gain in SNR for the HASTE and the in-phase sequence.
CONCLUSION: High-field abdominal MR imaging at 3.0 T offers significantly higher SNR compared with standard 1.5 T MR imaging.

Entities:  

Mesh:

Year:  2006        PMID: 16979073     DOI: 10.1016/j.acra.2006.06.018

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  10 in total

1.  3.0 Tesla magnetic resonance imaging: A new standard in liver imaging?

Authors:  Rossano Girometti
Journal:  World J Hepatol       Date:  2015-07-28

2.  Impact of field strength and RF excitation on abdominal diffusion-weighted magnetic resonance imaging.

Authors:  Philipp Riffel; Raghuram K Rao; Stefan Haneder; Mathias Meyer; Stefan O Schoenberg; Henrik J Michaely
Journal:  World J Radiol       Date:  2013-09-28

Review 3.  MRI of the liver--how to do it.

Authors:  Shreyas S Vasanawala
Journal:  Pediatr Radiol       Date:  2010-04

4.  Feasibility of 3-T MRI for the evaluation of Crohn disease in children.

Authors:  Charuta Dagia; Michael Ditchfield; Michael Kean; Anthony Catto-Smith
Journal:  Pediatr Radiol       Date:  2010-08-06

5.  Interplatform reproducibility of liver and spleen stiffness measured with MR elastography.

Authors:  Temel Kaya Yasar; Mathilde Wagner; Octavia Bane; Cecilia Besa; James S Babb; Stephan Kannengiesser; Maggie Fung; Richard L Ehman; Bachir Taouli
Journal:  J Magn Reson Imaging       Date:  2015-10-15       Impact factor: 4.813

Review 6.  Advances in pediatric body MRI.

Authors:  Shreyas S Vasanawala; Michael Lustig
Journal:  Pediatr Radiol       Date:  2011-08-17

7.  A paradoxical signal intensity increase in fatty livers using opposed-phase gradient echo imaging with fat-suppression pulses.

Authors:  Robert V Mulkern; Sandra Loeb Salsberg; Marta Ramon Krauel; David S Ludwig; Stephan Voss
Journal:  Pediatr Radiol       Date:  2008-08-02

Review 8.  Childhood extracranial neoplasms: the role of imaging in drug development and clinical trials.

Authors:  Lucy A Fowkes; Dow-Mu Koh; David J Collins; Neil P Jerome; David MacVicar; Sue C Chua; Andrew D J Pearson
Journal:  Pediatr Radiol       Date:  2015-06-05

9.  Resting myocardial perfusion quantification with CMR arterial spin labeling at 1.5 T and 3.0 T.

Authors:  Benjamin E Northrup; Kyle S McCommis; Haosen Zhang; Shuddhadeb Ray; Pamela K Woodard; Robert J Gropler; Jie Zheng
Journal:  J Cardiovasc Magn Reson       Date:  2008-11-17       Impact factor: 5.364

Review 10.  MRI of paediatric liver tumours: How we review and report.

Authors:  Susan C Shelmerdine; Derek J Roebuck; Alexander J Towbin; Kieran McHugh
Journal:  Cancer Imaging       Date:  2016-08-15       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.